BEDMINSTER, N.J. -- Bioject Medical Technologies Inc., a leading developer of needle-free drug delivery systems, announced today that the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently began its first human trial of a vaccine to prevent Ebola infection utilizing the Biojector 2000 (B-2000). The B-2000 is a needle-free injection system that is powered by a compressed gas system and is the only device being utilized in the study.
Earlier this year, Bioject had entered into a services and supply subcontract with SAIC-Frederick, Inc., a subsidiary of Science Applications International Corporation-Frederick (SAIC-Frederick) under its contract with the National Cancer Institute, Frederick, where by Bioject will supply the VRC/NIAID, with the non-exclusive right to utilize Bioject's B-2000 needle- free injection systems in VRC-sponsored clinical trials for experimental vaccines against HIV and Ebola. The HIV human clinical trials are currently underway.
Bioject Medical Technologies Inc., is an innovative developer and manufacturer of needle-free drug delivery systems and vial adapter products. Needle-free injection works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. The company is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies.
Source: Bioject Medical Technologies Inc.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.